Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-22 11:49 |
Verbale Assemblea 16 aprile 2024
|
Italian | 50.5 MB | ||
| 2024-05-22 11:49 |
Verbale Assemblea 16 aprile 2024
|
Italian | 50.5 MB | ||
| 2024-05-15 15:02 |
Interim management report as at 31 March 2024
|
English | 2.0 MB | ||
| 2024-05-15 14:59 |
Resoconto intermedio di gestione al 31 marzo 2024
|
Italian | 1.6 MB | ||
| 2024-05-15 14:57 |
Resoconto intermedio di gestione_Interim managment report
|
Italian | 177.8 KB | ||
| 2024-05-13 17:47 |
Pharmanutra - Results at 31 March 2024 approved
|
English | 380.6 KB | ||
| 2024-05-13 17:45 |
Pharmanutra_Approvati i risultati al 31 marzo 2024
|
Italian | 274.9 KB | ||
| 2024-04-19 13:08 |
Pharmanutra_rendiconto sintetico delle votazioni
|
Italian | 168.6 KB | ||
| 2024-04-19 12:51 |
Verbale CdA di approvazione della fusione
|
Italian | 4.5 MB | ||
| 2024-04-19 12:50 |
PHARMANUTRA avviso di disponibilità / notice of availability
|
Italian | 167.4 KB | ||
| 2024-04-16 13:21 |
PHARMANUTRA_PR post shareholders meeting
|
English | 304.1 KB | ||
| 2024-04-16 13:18 |
Pharmanutra_CS post assemblea
|
Italian | 191.2 KB | ||
| 2024-04-15 11:49 |
PR_Pharmanutra approved the merger by incorporation
|
English | 209.4 KB | ||
| 2024-04-15 11:48 |
CS_Pharmanutra approvata la fusione per incorporazione
|
Italian | 152.7 KB | ||
| 2024-03-26 10:29 |
Explanatory Memorandum on Authorisation to purchase and use trasury shares
|
English | 416.6 KB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
